H. B. Fuller Company (FUL) Coverage Initiated by Analysts at Robert W. Baird
Research analysts at Robert W. Baird initiated coverage on shares of H. B. Fuller Company (NYSE:FUL) in a report issued on Thursday, The Fly reports. The firm set a “neutral” rating on the specialty chemicals company’s stock.
Other equities analysts have also recently issued reports about the company. Zacks Investment Research raised H. B. Fuller from a “sell” rating to a “hold” rating in a report on Thursday, August 24th. BidaskClub cut H. B. Fuller from a “buy” rating to a “hold” rating in a report on Thursday, June 22nd. Deutsche Bank AG increased their target price on H. B. Fuller from $56.00 to $58.00 and gave the stock a “hold” rating in a report on Wednesday, September 6th. Finally, KeyCorp reissued a “hold” rating on shares of H. B. Fuller in a report on Thursday, August 24th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $55.60.
H. B. Fuller (NYSE FUL) traded down 0.05% during midday trading on Thursday, reaching $55.31. The company’s stock had a trading volume of 622,158 shares. H. B. Fuller has a 52 week low of $41.52 and a 52 week high of $55.70. The stock has a 50 day moving average of $51.48 and a 200 day moving average of $51.38. The firm has a market capitalization of $2.79 billion, a PE ratio of 25.28 and a beta of 1.69.
H. B. Fuller (NYSE:FUL) last issued its earnings results on Wednesday, June 28th. The specialty chemicals company reported $0.62 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.67 by ($0.05). H. B. Fuller had a return on equity of 13.32% and a net margin of 5.23%. The company had revenue of $561.65 million during the quarter. During the same period in the previous year, the firm posted $0.67 earnings per share. On average, equities research analysts predict that H. B. Fuller will post $2.59 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “H. B. Fuller Company (FUL) Coverage Initiated by Analysts at Robert W. Baird” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/14/h-b-fuller-company-ful-coverage-initiated-by-analysts-at-robert-w-baird.html.
In other news, VP Dietrich J. Crail acquired 970 shares of the firm’s stock in a transaction on Wednesday, July 12th. The shares were purchased at an average cost of $51.41 per share, for a total transaction of $49,867.70. Following the transaction, the vice president now owns 970 shares of the company’s stock, valued at $49,867.70. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 3.10% of the stock is currently owned by company insiders.
Institutional investors and hedge funds have recently made changes to their positions in the business. Bank of Montreal Can lifted its stake in shares of H. B. Fuller by 3.7% in the 1st quarter. Bank of Montreal Can now owns 8,356 shares of the specialty chemicals company’s stock valued at $431,000 after purchasing an additional 302 shares during the period. Strs Ohio lifted its stake in shares of H. B. Fuller by 7.7% in the 1st quarter. Strs Ohio now owns 4,200 shares of the specialty chemicals company’s stock valued at $216,000 after purchasing an additional 300 shares during the period. Russell Investments Group Ltd. acquired a new position in shares of H. B. Fuller in the 1st quarter valued at $442,000. Wells Fargo & Company MN lifted its stake in shares of H. B. Fuller by 22.8% in the 1st quarter. Wells Fargo & Company MN now owns 85,673 shares of the specialty chemicals company’s stock valued at $4,417,000 after purchasing an additional 15,896 shares during the period. Finally, Great West Life Assurance Co. Can lifted its stake in shares of H. B. Fuller by 6.2% in the 1st quarter. Great West Life Assurance Co. Can now owns 70,159 shares of the specialty chemicals company’s stock valued at $3,615,000 after purchasing an additional 4,090 shares during the period. Hedge funds and other institutional investors own 93.46% of the company’s stock.
H. B. Fuller Company Profile
H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.
Receive News & Ratings for H. B. Fuller Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller Company and related companies with MarketBeat.com's FREE daily email newsletter.